KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
No Result
View All Result
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Celltrion

Celltrion to Conduct Trials for COVID-19 Test Kit, Cure in Six months

 1,654 total views,  1 views today

James Jung by James Jung
PUBLISHED: March 13, 2020 UPDATED: March 18, 2020
in Celltrion, South Korea, Virus
0
celltrion-chairman
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion

Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion

Celltrion, South Korea’s leading biosimilar developer, said it doubled its efforts to create a super-fast test kit designed to identify COVID-19 and to develop a cure, which the company foresees would reach human clinical trial stage within six months.

 Seo Jung-jin, Celltrion’s Chairman, shared on a YouTube live stream on Thursday the group’s ongoing efforts on the coronavirus cure development. He said that the company aims to commercialize the kit within three months with a local partner.

Seo said that under normal circumstances, the process would take about 18 months, though, given the emergency in South Korea, they plan to initiate the use of antibodies on confirmed patients after six months. Celltrion would closely work with the Ministry of Food and Drug Safety to conduct the trials.

Celltrion secured a blood sample from a recovered coronavirus patient released from the Seoul National University College of Medicine. The company has also been gathering more samples from other institutes to use for screening antibodies required for the diagnostic kits. The biosimilar developer hopes to narrow down the antibody candidates by the end of March and select the most potent pipeline by the end of April.

The chairman said that as they are developing a cure, they would also develop diagnostic kits that can be used by people without the intervention of a medical professional.

Diasgnostic Kits

Hospitals widely use a method called quantitative reverse transcription PCR (RT-qPCR), but it takes a few hours to acquire results with very high accuracy. Meanwhile, a rapid diagnostic kit works faster but has low accuracy.

Celltrion intends to combine both methods benefiting from their advantages. The company plans to create a kit that could show results within 15 to 20 minutes with high accuracy.

Seo added that the company plans to conduct a phase 1 study to demonstrate safety, and a phase 3 trial for both safety and efficacy and side effects in up to 1,000 patients.

Furthermore, Celltrion would provide a total of 1 million masks to citizens of Cheongju, North Chungcheong Province, and Incheon, Gyeonggi Province. Both cities are where Celltrion’s operation facilities are located, said Seo.

Seo said that the commercial development of the new coronavirus treatment would cost at least $248.8 million (300 billion).

 “We are doing this so that Korea will become an exemplary case for eradicating COVID-19.”

– Celltrion Chairman Seo Jung-jin, during the YouTube live stream

Celltrion is still pursuing to establish China’s biggest biologics drug plant in the city of Wuhan.

What’s your thoughts?
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
Tags: Celltrionclinical trialscoronavirusCOVID-19curediagnostic kitsSouth Korea

Related Posts

South Korea gears up to bring World Expo 2030 to Busan
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
South Korea

South Korea gears up to bring World Expo 2030 to Busan

March 11, 2023
Samsung headquarters
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
South Korea

Korea’s top 100 companies’ economic contribution soar by 20%  in 9 years

July 20, 2022
South Korea curbs tech leaks to foreign countries
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
South Korea

South Korea curbs tech leaks to foreign countries

February 8, 2022
Hyundai Rotem set to provide upgraded army tank variants to South Korea
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
South Korea

Hyundai Rotem set to provide upgraded army tank variants to South Korea

February 2, 2022
S.Korea will track COVID-19 cases with AI-powered facial recognition from January
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
South Korea

S.Korea will track COVID-19 cases with AI-powered facial recognition from January

December 14, 2021
South Korea sets site engineering standards for big tech firms
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
Google

South Korea sets site engineering standards for big tech firms

December 9, 2021
No Result
View All Result

Follow Us

FREE NEWSLETTER




PRODUCTS

Most Popular

  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Top South Korean Tech Products to Look Out for in 2021

    0 shares
    Share 0 Tweet 0
  • Robots to help Police Patrol in South Korea

    0 shares
    Share 0 Tweet 0
  • 5 All-Time Best Rom-Com K-Dramas to Watch

    0 shares
    Share 0 Tweet 0
  • South Korea plans Urban Air Mobility Air Taxi services by 2025

    0 shares
    Share 0 Tweet 0
  • SK On to introduce South Korea’s first LFP Battery Prototype

    0 shares
    Share 0 Tweet 0
  • South Korea to commercialize Quantum Cryptography Communications

    0 shares
    Share 0 Tweet 0
  • Top Eight Promising EdTech Startup Companies in South Korea

    0 shares
    Share 0 Tweet 0
  • Netmarble subsidiary Metaverse Entertainment’s K-Pop virtual girl band MAVE has a smashing online debut

    0 shares
    Share 0 Tweet 0
  • KT Continues to Accelerate Its ‘Digico’ Transformation

    0 shares
    Share 0 Tweet 0
  • About Us
  • Account Page
  • application form
  • Cookie policy
  • Default Redirect Page
  • homepage
  • Login
  • login form
  • LogOut
  • Newsletter
  • Privacy Policy
  • Register
  • Reset Password
  • Sample Page
  • Subscription Plan
  • Terms of Use
  • test
  • test
  • testpage
  • TOS Page
  • Visitor Inside User Page

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |